Adverum Biotechnologies, Inc. (ADVM) Social Stream
ADVERUM BIOTECHNOLOGIES INC (ADVM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ADVERUM BIOTECHNOLOGIES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 6 | $13 | $3 | $6 | $0.835 | 618.56% |
| 2022-03-30 | 4 | $6 | $4 | $5 | $0.835 | 498.8% |
| 2022-04-11 | 4 | $4 | $3 | $3.5 | $0.835 | 319.16% |
| 2022-05-15 | 3 | $4 | $3 | $3.5 | $0.835 | 319.16% |
| 2022-05-27 | 3 | $3 | $3 | $3 | $0.835 | 259.28% |
| 2022-07-07 | 3 | $4 | $3 | $3.5 | $0.835 | 319.16% |
| 2022-08-15 | 3 | $4 | $2.5 | $3.25 | $0.835 | 289.22% |
| 2022-08-16 | 3 | $6 | $2.5 | $4.25 | $0.835 | 408.98% |
| 2022-11-14 | 3 | $6 | $2 | $3.666 | $0.835 | 339.04% |
| 2023-03-31 | 4 | $6 | $2 | $3.25 | $0.835 | 289.22% |
| 2023-05-12 | 5 | $6 | $2 | $3.25 | $0.835 | 289.22% |
| 2023-06-19 | 5 | $6 | $2 | $3.5 | $0.835 | 319.16% |
| 2023-07-18 | 5 | $6 | $2 | $3.75 | $0.835 | 349.1% |
| 2023-08-11 | 5 | $6 | $2 | $3.75 | $0.835 | 349.1% |
| 2023-08-14 | 5 | $6 | $3 | $4.25 | $0.835 | 408.98% |
| 2023-11-03 | 6 | $6 | $2 | $3.8 | $0.835 | 355.09% |
| 2023-11-15 | 6 | $6 | $2 | $4 | $0.835 | 379.04% |
The Trend in the Analyst Price Target
Over the past 15 months, ADVM's average price target has gone up $0.75.
Over the past 36 weeks, ADVM's average upside potential has been 264.89%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-31 | 4 | 6 | 2 | 3.25 | 0.717 | 353.28% |
| 2023-05-12 | 5 | 6 | 2 | 3.25 | 0.810 | 301.23% |
| 2023-05-15 | 5 | 6 | 2 | 3.50 | 0.830 | 321.69% |
| 2023-07-18 | 5 | 6 | 2 | 3.75 | 2.210 | 69.68% |
| 2023-11-03 | 6 | 6 | 2 | 4.00 | 0.931 | 329.65% |
ADVM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 5 | 0 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
ADVM's average broker recommendation rating improved by 0.77 over the prior 32 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ADVM as an investment opportunity.
- ADVM has a higher average analyst price target than 51.31% of all US stocks.
- ADVERUM BIOTECHNOLOGIES INC's upside potential (average analyst target price relative to current price) is greater than 1748.57% of all US stocks.
- In the context of Healthcare stocks, ADVERUM BIOTECHNOLOGIES INC's number of analysts covering the stock is greater than 373.11% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ADVERUM BIOTECHNOLOGIES INC's variance in analysts' estimates is lower than -1214.99% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ADVERUM BIOTECHNOLOGIES INC are CGEN, ONVO, and PALI.
View All Top Stocks by Price Target
What is the outlook for ADVM? Use POWR Ratings for clearer insight into price direction.